RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Daily Briefing

White House freezes all HHS communications, cancels meetings


The Trump administration has canceled a number of scientific meetings and instructed federal health officials to pause all public communications, leading to confusion and concern among some health experts.

Trump administration cancels meetings, freezes communications

In a memo obtained by the Associated Press, acting HHS Secretary Dorothy Fink told agency staff leaders there would be an "immediate pause" on regulations, guidance, announcements, press releases, social media posts, and website posts until those communications are approved by a political appointee.

This pause also applies to any rules and regulations slated to be published in the Federal Register, as well as CDC's Morbidity and Mortality Weekly Report. According to the memo, the pause is in effect through Feb. 1.

The directive was delivered throughout HHS' agencies, including CDC, FDA, and NIH.

In addition, a number of scientific meetings and panels have been canceled, including several meetings of NIH's study sections, which review applications for fellowships and grants, according to agency notices obtained by STAT. A meeting of the National Vaccine Advisory Committee on Feb. 20 and 21 was also canceled, as was a meeting of the Presidential Advisory Council for Combating Antibiotic-Resistant Bacteria that was scheduled for Jan. 28 and 29.

"HHS has issued a pause on mass communications and public appearances that are not directly related to emergencies or critical to preserving health," said a spokesperson for NIH. "This is a short pause to allow the new team to set up a process for review and prioritization. There are exceptions for announcements that HHS divisions believe are mission critical, but they will be made on a case-by-case basis."

However, Annika Barber, a molecular biologist at Rutgers University who is a member of an NIH study section slated to meet Feb. 20 and 21, said she was told the meeting was not canceled. "At least for now, it seems like this [scientific review officer] thinks that we will be meeting, and I was able to book my travel through the NIH World Travel website this afternoon and an Amtrak ticket was issued, so the NIH did pay for a train ticket, which also seems promising," Barber said.

 

Health experts react

Some experts said they expect a new administration to pause communications but expressed concern at the scope and unusual nature of this pause.

Steven Grossman, a former HHS official, said it's not unusual for an incoming administration to pause communications for review, but usually officials working on the president's transition team would have the process for issuing documents running smoothly by inauguration day.

"The executive branch is a hierarchy," Grossman said. "Whether stated publicly or not, every new administration wants important commitments and positions to wait until new teams are in place and some semblance of hierarchy restored."

"It's not unusual for a new administration to want to centralize communication," said Richard Besser, CEO of the Robert Wood Johnson Foundation and former acting director of CDC. "It is unusual to pause all communication from an agency where one of its critical responsibilities is keeping the public informed," he added.

Chrissie Juliano, executive director of the Big Cities Health Coalition, said state and city health officials rely on CDC notices to make decisions for their communities, like when to increase flu testing or which disease symptoms to be on the lookout for. While a lot of that information can be delayed a few days, Juliano said she hopes the administration has a plan for disseminating more pressing public health information, especially relating to the ongoing bird flu outbreak.

"Can something like the bird flu turn on a dime in 10 days?" Juliano said. "Yes. I would hope that if those signals are seen at the federal level, information is going to get out."

It's also possible that canceling scientific meetings could have repercussions in the future.

"Peer review via study sections is required by law in order for the NIH to disburse most of the $40 billion annual extramural budget," said Norman Sharpless, a former director of the National Cancer Institute. "If study sections and advisory council meetings are postponed for more than even a brief period, this will likely lead to interruptions in grant funding, which is bad for U.S. biomedical research."

"Anything that disrupts study sections for a period of time, from government shutdowns to major weather events, can backlog and slow down the whole system, especially since study section members tend to be busy people who can be hard to schedule. Virtual study sections make it easier, but it can be disruptive," said Carrie Wolinetz, chair of the health bioscience innovations practice at Lewis-Burke Associates and former senior adviser at NIH.

"This is super stressful because of the uncertainty of not knowing how long these cancellations be in effect. If study sections don't meet on time, then that could delay grants being distributed, which affects the ability of labs to pay their students and postdocs and staff. In some cases, if there was a gap in funding, it could result in someone either not being hired at all or having to be laid off," said Rebecca Pompano, a chemist and biomedical engineer at the University of Virginia whose training session for a study section was canceled 20 minutes before it was scheduled to start.

"With [government] shutdowns, we all know eventually it will reopen, and so it's always seen as temporary," Pompano added. "But this one is more stressful because there's been a lot of talk from [Robert F. Kennedy Jr.] about overhauling the NIH extensively."

(Saric, Axios, 1/22; Oza, STAT, 1/22; Stobbe/Aleccia, Associated Press, 1/22; Rosenbluth et. al., New York Times, 1/23)


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

RELATED RESOURCES

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.